Digestive & Intestinal Remedies (Pharmacies) - France

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$336.70m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.46%, resulting in a market volume of US$344.60m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$5.19 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in France is experiencing significant growth and development.

Customer preferences: Customers in France are increasingly seeking digestive and intestinal remedies to address common gastrointestinal issues such as indigestion, bloating, and acid reflux. This is driven by a growing awareness of the importance of digestive health and an increasing focus on self-care. Consumers are looking for effective and convenient remedies that provide quick relief from these symptoms. They also prefer natural and organic products that are perceived to be gentler on the digestive system.

Trends in the market: One major trend in the Digestive & Intestinal Remedies market in France is the rising demand for probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and promote healthy digestion. The increasing popularity of probiotics is driven by their proven efficacy in improving digestive health and their ability to boost the immune system. As a result, there is a growing number of probiotic products available in pharmacies, including probiotic supplements, yogurts, and fermented foods. Another trend in the market is the growing demand for natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of conventional medicines and are seeking alternative options. Herbal remedies, such as herbal teas and supplements, are perceived to be safer and gentler on the digestive system. They are also believed to have fewer side effects. This trend is supported by the increasing availability of natural and herbal products in pharmacies.

Local special circumstances: France has a strong tradition of using natural remedies for various ailments, including digestive issues. This cultural preference for natural and herbal remedies has contributed to the growing demand for natural digestive and intestinal remedies in the market. The French market also benefits from a well-developed pharmacy network, which makes it convenient for consumers to access a wide range of products.

Underlying macroeconomic factors: The growth in the Digestive & Intestinal Remedies market in France can be attributed to several macroeconomic factors. Firstly, the aging population in France is driving the demand for digestive and intestinal remedies. As people age, they are more likely to experience digestive issues and seek remedies to manage these symptoms. Secondly, the increasing prevalence of sedentary lifestyles and unhealthy diets is leading to a higher incidence of digestive problems. This is creating a larger market for remedies that address these issues. Lastly, the rising healthcare costs in France are encouraging consumers to take a proactive approach to their health and seek remedies for common ailments before seeking medical intervention. In conclusion, the Digestive & Intestinal Remedies market in France is experiencing growth and development due to customer preferences for effective and convenient remedies, trends towards probiotics and natural remedies, local cultural preferences, and underlying macroeconomic factors such as the aging population and changing lifestyles.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.